Xuedong Dai

Statistics

Publications

Citations

326

H-Index

Active since

1998

Affiliations

Massachusetts Institute of Technology(Current)

Age UK

GlaxoSmithKline (China)

Xuedong Dai is an author at Massachusetts Institute of Technology specializing in medicinal chemistry, synthetic medicinal chemistry, and organic chemistry.

ORCID

Publications per year

1998–2022

Publications

Synthesis and Resolution of Quinazolinone Atropisomeric Phosphine Ligands<sup>,</sup>

Xuedong Dai, Audrey Wong, Scott C. Virgil · The Journal of Organic Chemistry · 1998 · 88 citations

Natural Sciences, Chemistry, Medicinal Chemistry +10

An improved synthesis of a selective αvβ3-integrin antagonist cyclo(-RGDfK-)

Xuedong Dai, Zhuang Su, Jun O. Liu · Tetrahedron Letters · 2000 · 49 citations

Pharmacy, Medicinal Chemistry, Pharmacology +11

Asymmetric allylic alkylation catalyzed by palladium complexes with atropisomeric quinazolinone phosphine ligands

Xuedong Dai, Scott C. Virgil · Tetrahedron Letters · 1999 · 49 citations

Natural Sciences, Chemistry, Medicinal Chemistry +13

Deletion of PI3K-p85α gene impairs lineage commitment, terminal maturation, cytokine generation and cytotoxicity of NK cells

Aradhana Awasthi, Asanga Samarakoon, Xuedong Dai et al. · Genes and Immunity · 2008 · 32 citations

Life Sciences, Immunology, Molecular Biology +16

Discovery of 5-substituent-N-arylbenzamide derivatives as potent, selective and orally bioavailable LRRK2 inhibitors

Xiao Ding, Xuedong Dai, Kai Long et al. · Bioorganic & Medicinal Chemistry Letters · 2017 · 23 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +12

1–5 of 10